Myopathy

Investigation of muscle weakness and disease.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
NeurologyRheumatology

Clinical Guidelines

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy
National
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy
National
ESC/EAS Guidelines for the management of dyslipidaemias
National
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Local
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy
Local
2022 HRS expert consensus statement on evaluation and management of arrhythmogenic cardiomyopathy
Local
British Society for Rheumatology guideline on management of adults with idiopathic inflammatory myopathy
Local
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
Local
Consensus Statement on Standard of Care for Congenital Myopathies
Local
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) Initiative
Local
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Local
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline
Local